KIT and ovarian cancer: Characterisation of the SW620 spheroids indicated TG2 was upregulated in the spheroid cells compared to cells grown in monolayer, in agreement with Cao et al. [17] in ovarian cancer cells where cells also showed increased stem cell characteristics CD44+/CD117+.